- All Drug Categories
- Home
- Anti-cancer Drugs
- Healthcare Products
- Medical Information
- Statement
The medication of Capmatinib in special populations needs to be adjusted or discontinued according to pregnancy, lactation, liver and kidney fu...
Capmatinib is a MET inhibitor used to treat metastatic non-small cell lung cancer with MET exon 14 jump mutation. The dosage should be adjusted...
Biktarvy should be adjusted according to physiological conditions when used in special populations. Maternal and infant risks should be evaluat...
Biktarvy, as an HIV compound preparation, commonly has side effects including headache, diarrhea, and metabolic abnormalities. Most symptoms ar...
Nintedanib is a multi-target tyrosine kinase inhibitor mainly used for the treatment of idiopathic pulmonary fibrosis (IPF). It is necessary to...
Ethanesulfonate Nidanib Soft Capsules (OFEV) are designed for special populations such as pregnancy, lactation, and liver and kidney dysfunctio...
The side effects of Baricitinib mainly include increased risk of infection, blood system abnormalities, and gastrointestinal reactions, which r...
Baricitinib is a JAK inhibitor mainly used to treat autoimmune diseases such as rheumatoid arthritis. Its standard dose is 2mg or 4mg orally on...
Baricitinib is suitable for patients with specific rheumatic and immune diseases, but its safety needs to be evaluated based on age, liver and ...
Baricitinib, as a JAK inhibitor, should be used with a focus on infection risk, thrombotic events, and medication safety in special populations...
